Applications of inorganic nanoparticles as therapeutic agents

During the last decade, various functional nanostructured materials with interesting optical, magnetic, mechanical and chemical properties have been extensively applied to biomedical areas including imaging, diagnosis and therapy. In therapeutics, most research has focused on the application of nanoparticles as potential delivery vehicles for drugs and genes, because nanoparticles in the size range of 2–100 nm can interact with biological systems at the molecular level, and allow targeted delivery and passage through biological barriers. Recent investigations have even revealed that several kinds of nanomaterials are intrinsically therapeutic. Not only can they passively interact with cells, but they can also actively mediate molecular processes to regulate cell functions. This can be seen in the treatment of cancer via anti-angiogenic mechanisms as well as the treatment of neurodegenerative diseases by effectively controlling oxidative stress. This review will present recent applications of inorganic nanoparticles as therapeutic agents in the treatment of disease.

[1]  M. Epple,et al.  Silver as antibacterial agent: ion, nanoparticle, and metal. , 2013, Angewandte Chemie.

[2]  Pablo Del Pino,et al.  Interfacing engineered nanoparticles with biological systems: anticipating adverse nano-bio interactions. , 2013, Small.

[3]  X. Fang,et al.  Protective effect of C70-carboxyfullerene against oxidative-induced stress on postmitotic muscle cells. , 2013, ACS applied materials & interfaces.

[4]  E. Wang,et al.  Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle , 2013, Proceedings of the National Academy of Sciences.

[5]  Bing Wang,et al.  Metabolism of nanomaterials in vivo: blood circulation and organ clearance. , 2013, Accounts of chemical research.

[6]  W. Kreyling,et al.  Differences in the biokinetics of inhaled nano- versus micrometer-sized particles. , 2013, Accounts of chemical research.

[7]  Tian Xia,et al.  Physicochemical properties determine nanomaterial cellular uptake, transport, and fate. , 2013, Accounts of chemical research.

[8]  Lang Tran,et al.  The biologically effective dose in inhalation nanotoxicology. , 2013, Accounts of chemical research.

[9]  Amit Kumar,et al.  Effects of cerium oxide nanoparticles on the growth of keratinocytes, fibroblasts and vascular endothelial cells in cutaneous wound healing. , 2013, Biomaterials.

[10]  N. Hanagata,et al.  Oxide-based inorganic/organic and nanoporous spherical particles: synthesis and functional properties , 2013, Science and technology of advanced materials.

[11]  C. Barbante,et al.  Active Silver Nanoparticles for Wound Healing , 2013, International journal of molecular sciences.

[12]  Matthias Epple,et al.  Silver as antibacterial agent: ion, nanoparticle, and metal. , 2013, Angewandte Chemie.

[13]  Shailendra Giri,et al.  Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer , 2013, PloS one.

[14]  Sudipta Seal,et al.  Sustained protection against photoreceptor degeneration in tubby mice by intravitreal injection of nanoceria. , 2012, Biomaterials.

[15]  Dohoung Kim,et al.  Ceria nanoparticles that can protect against ischemic stroke. , 2012, Angewandte Chemie.

[16]  Soumen Das,et al.  Harnessing nanoparticles to improve toxicity after head and neck radiation. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[17]  Morteza Mahmoudi,et al.  Antibacterial properties of nanoparticles. , 2012, Trends in biotechnology.

[18]  Leaf Huang,et al.  Recent advances in nonviral vectors for gene delivery. , 2012, Accounts of chemical research.

[19]  P. Tran,et al.  Nanomaterial-based treatments for medical device-associated infections. , 2012, Chemphyschem : a European journal of chemical physics and physical chemistry.

[20]  Rachel A. Kudgus,et al.  Intrinsic Therapeutic Applications of Noble Metal Nanoparticles: Past, Present and Future , 2012 .

[21]  Mahesh K. Gangishetty,et al.  Studies on antibacterial activity of ZnO nanoparticles by ROS induced lipid peroxidation. , 2012, Colloids and surfaces. B, Biointerfaces.

[22]  Z. Aziz,et al.  A systematic review of silver-containing dressings and topical silver agents (used with dressings) for burn wounds. , 2012, Burns : journal of the International Society for Burn Injuries.

[23]  Silvia Licoccia,et al.  Cerium oxide nanoparticles protect cardiac progenitor cells from oxidative stress. , 2012, ACS nano.

[24]  Taeghwan Hyeon,et al.  Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. , 2012, Chemical Society reviews.

[25]  M. Ahamed,et al.  Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species , 2012, International journal of nanomedicine.

[26]  Wei Wang,et al.  Cytotoxicity induced by engineered silver nanocrystallites is dependent on surface coatings and cell types. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[27]  Zainab N. Khan,et al.  Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. , 2012, Cancer cell.

[28]  Marc Schneider,et al.  Novel approaches for drug delivery systems in nanomedicine: effects of particle design and shape. , 2012, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[29]  Kaushal Rege,et al.  Inorganic nanoparticles for cancer imaging and therapy. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[30]  Yu-feng Li,et al.  Fate and toxicity of metallic and metal-containing nanoparticles for biomedical applications. , 2011, Small.

[31]  J. Chipman,et al.  Silver and nanoparticles of silver in wound dressings: a review of efficacy and safety. , 2011, Journal of wound care.

[32]  R. Duncan,et al.  Nanomedicine(s) under the microscope. , 2011, Molecular pharmaceutics.

[33]  Kinam Park,et al.  Targeted drug delivery to tumors: myths, reality and possibility. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[34]  Kazunori Kataoka,et al.  Supramolecular nanodevices: from design validation to theranostic nanomedicine. , 2011, Accounts of chemical research.

[35]  Soumen Das,et al.  PEGylated Inorganic Nanoparticles , 2011 .

[36]  Jian Zhang,et al.  Physical and chemical stability of drug nanoparticles. , 2011, Advanced drug delivery reviews.

[37]  Erin Lavik,et al.  The role of nanomaterials in translational medicine. , 2011, ACS nano.

[38]  E. Traversa,et al.  Pharmacological potential of cerium oxide nanoparticles. , 2011, Nanoscale.

[39]  K. Jeyasubramanian,et al.  Selective toxicity of ZnO nanoparticles toward Gram-positive bacteria and cancer cells by apoptosis through lipid peroxidation. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[40]  S. Sahoo,et al.  PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. , 2011, Advanced drug delivery reviews.

[41]  Jun Fang,et al.  The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. , 2011, Advanced drug delivery reviews.

[42]  Suntharampillai Thevuthasan,et al.  PEGylated inorganic nanoparticles. , 2011, Angewandte Chemie.

[43]  Wendelin J Stark,et al.  Nanoparticles in biological systems. , 2011, Angewandte Chemie.

[44]  Peter L. Irwin,et al.  Antibacterial Activity and Mechanism of Action of Zinc Oxide Nanoparticles against Campylobacter jejuni , 2011, Applied and Environmental Microbiology.

[45]  P. Couvreur,et al.  Superior preclinical efficacy of gemcitabine developed as chitosan nanoparticulate system. , 2011, Biomacromolecules.

[46]  S. Seal,et al.  Redox-active radical scavenging nanomaterials. , 2010, Chemical Society reviews.

[47]  Molly M. Stevens,et al.  Rare earth oxides as nanoadditives in 3-D nanocomposite scaffolds for bone regeneration , 2010 .

[48]  P. Kupelian,et al.  Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[49]  S. Gurunathan,et al.  Antitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor model , 2010, International journal of nanomedicine.

[50]  Manuela Semmler-Behnke,et al.  Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. , 2010, Biomaterials.

[51]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[52]  G. Sotiriou,et al.  Antibacterial activity of nanosilver ions and particles. , 2010, Environmental science & technology.

[53]  Silvia Licoccia,et al.  Stem Cell Aligned Growth Induced by CeO2 Nanoparticles in PLGA Scaffolds with Improved Bioactivity for Regenerative Medicine , 2010 .

[54]  S. Seal,et al.  Nanoceria exhibit redox state-dependent catalase mimetic activity. , 2010, Chemical communications.

[55]  Katsumi Kobayashi,et al.  Platinum nanoparticles: a promising material for future cancer therapy? , 2010, Nanotechnology.

[56]  Jeffrey I. Zink,et al.  Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery , 2010, BiOS.

[57]  C. Rodríguez-Padilla,et al.  Mode of antiviral action of silver nanoparticles against HIV-1 , 2010, Journal of nanobiotechnology.

[58]  Sudipta Seal,et al.  Anti-inflammatory properties of cerium oxide nanoparticles. , 2009, Small.

[59]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[60]  Chenjie Xu,et al.  FePt nanoparticles as an Fe reservoir for controlled Fe release and tumor inhibition. , 2009, Journal of the American Chemical Society.

[61]  Wei Li,et al.  Fullerene nanoparticles selectively enter oxidation-damaged cerebral microvessel endothelial cells and inhibit JNK-related apoptosis. , 2009, ACS nano.

[62]  Ramanathan Vaidyanathan,et al.  Antiangiogenic properties of silver nanoparticles. , 2009, Biomaterials.

[63]  B. Delley,et al.  Stability and morphology of cerium oxide surfaces in an oxidizing environment: A first-principles investigation , 2009 .

[64]  V. Torchilin,et al.  ATP-loaded liposomes for treatment of myocardial ischemia. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[65]  Sudipta Seal,et al.  Protection from radiation-induced pneumonitis using cerium oxide nanoparticles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[66]  Chenjie Xu,et al.  Dumbbell-like Au-Fe3O4 nanoparticles for target-specific platin delivery. , 2009, Journal of the American Chemical Society.

[67]  Stefan Bräse,et al.  Cellular uptake of platinum nanoparticles in human colon carcinoma cells and their impact on cellular redox systems and DNA integrity. , 2009, Chemical research in toxicology.

[68]  Lisa Brannon-Peppas,et al.  Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.

[69]  Taeghwan Hyeon,et al.  Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. , 2008, Angewandte Chemie.

[70]  Wenbin Lin,et al.  Manganese-based nanoscale metal-organic frameworks for magnetic resonance imaging. , 2008, Journal of the American Chemical Society.

[71]  Xing-Jie Liang,et al.  Inhibition of Tumor Growth by Endohedral Metallofullerenol Nanoparticles Optimized as Reactive Oxygen Species Scavenger , 2008, Molecular Pharmacology.

[72]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[73]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.

[74]  Wenbin Lin,et al.  Nanoscale coordination polymers for platinum-based anticancer drug delivery. , 2008, Journal of the American Chemical Society.

[75]  C. Robic,et al.  Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.

[76]  J. Imlay Cellular defenses against superoxide and hydrogen peroxide. , 2008, Annual review of biochemistry.

[77]  Sudipta Seal,et al.  The role of cerium redox state in the SOD mimetic activity of nanoceria. , 2008, Biomaterials.

[78]  Monty Liong,et al.  Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. , 2008, ACS nano.

[79]  Petra Krystek,et al.  Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.

[80]  Yunqing Kang,et al.  Toxicological effect of ZnO nanoparticles based on bacteria. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[81]  K. Tsuchida,et al.  Recent advances in inorganic nanoparticle-based drug delivery systems. , 2008, Mini reviews in medicinal chemistry.

[82]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[83]  M. Hall,et al.  Basis for design and development of platinum(IV) anticancer complexes. , 2007, Journal of medicinal chemistry.

[84]  M. Atkinson,et al.  Novel synthesis of cerium oxide nanoparticles for free radical scavenging. , 2007, Nanomedicine.

[85]  Yulong Ding,et al.  Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids) , 2007 .

[86]  M. Das,et al.  Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. , 2007, Biomaterials.

[87]  S. Seal,et al.  Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. , 2007, Chemical communications.

[88]  L. Rogers,et al.  Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. , 2007, Cardiovascular research.

[89]  J. Song,et al.  Does the Antibacterial Activity of Silver Nanoparticles Depend on the Shape of the Nanoparticle? A Study of the Gram-Negative Bacterium Escherichia coli , 2007, Applied and Environmental Microbiology.

[90]  Claudio Campa,et al.  Targeting VEGF-A to treat cancer and age-related macular degeneration. , 2007, Annual review of medicine.

[91]  Bing Xu,et al.  FePt@CoS(2) yolk-shell nanocrystals as a potent agent to kill HeLa cells. , 2007, Journal of the American Chemical Society.

[92]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[93]  R. Langer,et al.  Nanomedicine: developing smarter therapeutic and diagnostic modalities. , 2006, Advanced drug delivery reviews.

[94]  S. Seal,et al.  Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides , 2006, Nature nanotechnology.

[95]  Alex M. Fichtenholtz,et al.  Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery. , 2006, Small.

[96]  S. Silver,et al.  Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds , 2006, Journal of Industrial Microbiology and Biotechnology.

[97]  M. Benedetti,et al.  Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. , 2006, Nano letters.

[98]  Robert N Grass,et al.  In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. , 2006, Environmental science & technology.

[99]  Napoleone Ferrara,et al.  Angiogenesis as a therapeutic target , 2005, Nature.

[100]  P. Liljeroth,et al.  Physicochemical evaluation of the hot-injection method, a synthesis route for monodisperse nanocrystals. , 2005, Small.

[101]  H. Maeda,et al.  The EPR Effect and Polymeric Drugs: A Paradigm Shift for Cancer Chemotherapy in the 21st Century , 2005 .

[102]  R. Tarnuzzer,et al.  Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. , 2005, Nano letters.

[103]  Ling Zhou,et al.  Electron Localization Determines Defect Formation on Ceria Substrates , 2005, Science.

[104]  Ling Wang,et al.  Antiangiogenic Properties of Gold Nanoparticles , 2005, Clinical Cancer Research.

[105]  Chad A Mirkin,et al.  Nanostructures in biodiagnostics. , 2005, Chemical reviews.

[106]  Fumin Wang,et al.  Hydrothermal Synthesis of Highly Crystallized Lepidocrocite Nanosheets of TiO2 under Low Temperature , 2005 .

[107]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[108]  A. Shah,et al.  Role of oxidative stress in cardiac remodelling after myocardial infarction. , 2004, Heart, lung & circulation.

[109]  J. Guggenbichler,et al.  Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. , 2004, International journal of antimicrobial agents.

[110]  L. Ho,et al.  Differential effects of carboxyfullerene on MPP+/MPTP-induced neurotoxicity , 2004, Neurochemistry International.

[111]  P. Alivisatos The use of nanocrystals in biological detection , 2004, Nature Biotechnology.

[112]  J. Imlay,et al.  Pathways of oxidative damage. , 2003, Annual review of microbiology.

[113]  J. Sawai Quantitative evaluation of antibacterial activities of metallic oxide powders (ZnO, MgO and CaO) by conductimetric assay. , 2003, Journal of microbiological methods.

[114]  S. Moghimi,et al.  Real‐time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage‐prone nanoparticles to stealth entities by poloxamine 908 , 2003, FEBS letters.

[115]  K. Hwang,et al.  Fullerene derivative attenuates ischemia-reperfusion-induced lung injury. , 2003, Life sciences.

[116]  Sung-Wook Choi,et al.  Surface Modification of Functional Nanoparticles for Controlled Drug Delivery , 2003 .

[117]  H. Dvorak Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[118]  W. Dröge Free radicals in the physiological control of cell function. , 2002, Physiological reviews.

[119]  J. Rieger,et al.  Organic Nanoparticles in the Aqueous Phase-Theory, Experiment, and Use. , 2001, Angewandte Chemie.

[120]  Taeghwan Hyeon,et al.  Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. , 2001, Journal of the American Chemical Society.

[121]  C. Niemeyer REVIEW Nanoparticles, Proteins, and Nucleic Acids: Biotechnology Meets Materials Science , 2022 .

[122]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[123]  H. Maeda The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. , 2001, Advances in enzyme regulation.

[124]  K. Davies,et al.  Mitochondrial free radical generation, oxidative stress, and aging. , 2000, Free radical biology & medicine.

[125]  D. Sorescu,et al.  NAD(P)H oxidase: role in cardiovascular biology and disease. , 2000, Circulation research.

[126]  V. Torchilin,et al.  Drug targeting. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[127]  C. K. Shen,et al.  C(60) and water-soluble fullerene derivatives as antioxidants against radical-initiated lipid peroxidation. , 1999, Journal of medicinal chemistry.

[128]  C. Giandomenico,et al.  Current status of platinum-based antitumor drugs. , 1999, Chemical reviews.

[129]  Tronc,et al.  Size Tailoring of Magnetite Particles Formed by Aqueous Precipitation: An Example of Thermodynamic Stability of Nanometric Oxide Particles. , 1998, Journal of colloid and interface science.

[130]  Shen,et al.  Carboxyfullerenes as neuroprotective agents. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[131]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[132]  V. Torchilin,et al.  Which polymers can make nanoparticulate drug carriers long-circulating? , 1995 .

[133]  G. Paravicini,et al.  Mechanism of irreversible inactivation of phosphomannose isomerases by silver ions and flamazine. , 1995, Biochemistry.

[134]  J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[135]  Jürgen-Hinrich Fuhrhop,et al.  Micelles and microemulsions , 1994 .

[136]  B. Beaudoin,et al.  Homogeneous and heterogeneous nucleations in the polyol process for the preparation of micron and submicron size metal particles , 1989 .

[137]  R. Massart,et al.  Preparation of aqueous magnetic liquids in alkaline and acidic media , 1981 .